pradimicins B (2) and C (3)3~5). Pradimicin A (1) wasfound to be active in vitro against a wide variety of fungi and yeasts, and highly effective against systemic fungal infections in mice5 '6) . Comparative in vitro studies showed that there was no cross-resistance to other antifungal agents and that 1 inhibited the growth of. 5-fluorocytosineand amphotericin B-resistant Candida albicanslt5). However, as pradimicin A (1) is hardly soluble in phosphate-buffered saline (PBS) at physiological pH' s, it is difficult to develop 1 as an injectable drug.
As part of the program aimed at identifying pharmaceutically acceptable structures, we embarked on chemical modification studies of 1 which has a novel 5,6-dihydrobenzo[a]naphthacene chromophore substituted with D-alanine and 2 sugars. We initially focused on the D-alanine moiety of 1, and report here the synthesis and physico-chemical properties of 17-epipradimicin A (4), and the effect of change in stereochemistry at the C-17 position on the activity of pradimicin A (1). Each sample was taken up in PBS containing 0.9mMof CaCl2 and 0.5 him of MgCl2, pH 7.2, sonicated at 30°C for 10 minutes and the insoluble material was removed by centrifugation at 12,000rpm for 10 minutes. The supernatant was diluted 5-fold with 0.01 n NaOHand the ODat 500nm was read. Concentration of each compound was calculated from the ODreading compared with the standard curve of each compound. The MICs were determined by the serial 2-fold agar dilution method in yeast morphology agar mediumbuffered with 0.067M phosphate, pH 7.0. Each sample was mixed with acetone-dried cells of C. albicans A9540 (l mg/ml) in 0.1 m phosphate buffer containing 0.2mM of CaCl2, 2% polyvinylpyrrolidone and 1% DMSO,pH 7.2, for 15 minutes at 25°C and the cells were removed by centrifugation. The quantity of material bound to the cells was calculated from the total amount used and the amount in the supernatant.
Synthesis
Transformation of pradimicin A (1) into 17-epipradimicin A (4) was carried out through the following steps. Upon treatment with benzyl chloroformate (5.0ml) and Na2CO3 (7.5g) in a mixture of acetone (400ml) and water (400ml) followed by hydrolysis, 1 (2.5g) was converted to iV-(benzyloxycarbonyl)pradimicin A (5a) (2.2g (76% yield); UV (0.01n NaOH-methanol (1 : 1)) Amaxnm (e) 319.2 (15,400), 498.4 (14,500); IR (KBr) cm"1 3450, 1735, 1630, 1605, 700). Treatment of5a (200mg) with formic acetic anhydride (20ml) at 60°C for 30 minutes followed by hydrolysis with NaOHgave a mixture of 5a and 5b which was hydrogenolyzed over 5% Pd-C (200 mg) in a mixture of methanol (40ml), ethanol (10ml) and water (20 ml PBS was given in Table 1 .
Stereochemi stry
The spectral data did not allow us to distinguish between the natural product (1)3) and its epimer (4). In addition, we have found an interesting phenomenonwhich seems to be consistent with the antifungal activity. While active 1 bound to the cell surface of C. albicans in the presence of Ca2+, inactive 4 had virtually no binding activity under the same conditions ( Table 1 ). The binding of 1 to the cell surface appears to be the first event which subsequently induces an alteration in cellular permeability, ultimately leading to death of the cells7). One can speculate that the amino acid moiety is one of the key structural elements for binding to the cell surface and that the inactivity of4 may have resulted from the inability of the L-alanine side chain to assumea geometry required for binding to the cell surface due to steric effects of the two neighboring substituents (a hydroxy group at C-l and a methyl group at C-3).
Interestingly, both the d-and L-alanines fed to growing cultures of A. hibisca were efficiently incorporated into the D-alanine side chain of 1 whereas 4 could not be detected in the crude fermentation broth8). This raises a possibility that pradimicin analogs which have a different D-amino acid chain may be produced by feeding an AUG. 1990 appropriate precursor to growing cultures of A.
hibisca.
